???pagination.result.count???
???pagination.result.page???
1
Cloning and characterization of a P2X receptor expressed in the central nervous system of Lymnaea stagnalis. , Bavan S., PLoS One. January 1, 2012; 7 (11): e50487.
A P2X receptor from the tardigrade species Hypsibius dujardini with fast kinetics and sensitivity to zinc and copper. , Bavan S., BMC Evol Biol. January 20, 2009; 9 17.
Inhibition of platelet functions and thrombosis through selective or nonselective inhibition of the platelet P2 receptors with increasing doses of NF449 [4,4',4'',4'''-(carbonylbis(imino-5,1,3-benzenetriylbis-(carbonylimino)))tetrakis-benzene-1,3-disulfonic acid octasodium salt]. , Hechler B., J Pharmacol Exp Ther. July 1, 2005; 314 (1): 232-43.
NF449: a subnanomolar potency antagonist at recombinant rat P2X1 receptors. , Braun K., Naunyn Schmiedebergs Arch Pharmacol. September 1, 2001; 364 (3): 285-90.
Structure-activity relationships of pyridoxal phosphate derivatives as potent and selective antagonists of P2X1 receptors. , Kim YC., J Med Chem. February 1, 2001; 44 (3): 340-9.
Selectivity of diadenosine polyphosphates for rat P2X receptor subunits. , Wildman SS., Eur J Pharmacol. February 12, 1999; 367 (1): 119-23.
A pyridoxine cyclic phosphate and its 6-azoaryl derivative selectively potentiate and antagonize activation of P2X1 receptors. , Jacobson KA., J Med Chem. June 18, 1998; 41 (13): 2201-6.